[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356655-105":59,"doc-detail-356655-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","chemokinechemokine-receptor-axis-emerging-immunotherapeutic-paradigms-for-solid-tumor-microenvironment-reprogramming","Chemokine–chemokine receptor axis - Emerging immunotherapeutic paradigms for solid tumor microenvironment reprogramming","","Chemokines regulate immune-cell infiltration and their interactions with cancer cells in the tumor microenvironment (TME). When chemokine gradients are disrupted, recruitment and activation of immune cells, as well as tumor proliferation, metastasis, and angiogenesis, are altered. By tuning these processes, chemokines can drive immunosuppressive or immunostimulatory states with pro- or antitumor outcomes. Dysregulated chemokine/chemokine-receptor expression links to tumor initiation, progression, and clinical outcomes, making the receptor axis a key immunotherapy target. This review maps chemokine expression across tumor types and summarizes receptor-mediated interactions and therapeutic targeting strategies, including combinations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chemokinechemokine-receptor-axis-emerging-immunotherapeutic-paradigms-for-solid-tumor-microenvironment-reprogramming/356655/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chemokinechemokine-receptor-axis-emerging-immunotherapeutic-paradigms-for-solid-tumor-microenvironment-reprogramming/356655.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do chemokines influence immune cell behavior in the tumor microenvironment?","Question",{"text":112,"@type":113},"Chemokines control immune-cell trafficking, activation, and communication by regulating spatial and temporal expression, thereby shaping the immunological landscape in the TME.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What happens when chemokine gradients are disrupted?",{"text":117,"@type":113},"Disrupted chemokine gradients alter immune cell recruitment and activation and can also influence tumor cell proliferation, metastasis, and angiogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is the chemokine receptor axis considered a promising target for cancer immunotherapy?",{"text":121,"@type":113},"Dysregulated expression of chemokines and their receptors is strongly linked to tumor initiation, progression, and clinical outcomes, and receptor-mediated signaling offers actionable therapeutic routes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356655,1790738121,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review Article  \nChemokine–chemokine receptor axis: Emerging immunotherapeutic paradigms for solid tumor microenvironment reprogramming  \nYang Zhao1,2, Xueqian Wang3,4, Tong Lei1,2, Hezhe Lu1,2, Yong Zhao3,4, Guiying Wang5,6  \n1State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China;  \n2Institute of Cell and Gene Technology, Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China;  \n3Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen, Guangdong 518107, China;  \n4Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China;  \n5General Surgery Department, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China;  \n6General Surgery Department, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, China.  \nAbstract  \nChemokines play a critical role in regulating immune cell infiltration and their interactions with cancer cells in the tumor microenvironment (TME). Disrupted chemokine gradients influence immune cell recruitment and activation, as well as tumor cell proliferation, metastasis, and angiogenesis. By modulating these processes, chemokines shape the immune landscape of the tumor microenvironment, driving either immunosuppressive or immunostimulatory responses with corresponding pro- or antitumor effects. Dysregulated expression of chemokines and their receptors is strongly associated with tumor initiation, progression, and clinical outcomes. As a result, the chemokine receptor axis has gained prominence as a therapeutic target in cancer immunotherapy. This review explores chemokine expression profiles across various tumor types and their receptor-mediated interactions with immune cells. It also summarizes current strategies to therapeutically target chemokine signaling, both as standalone interventionsand in combination with other treatment modalities.  \nKeywords: Chemokines; Chemokine receptors; Tumor microenvironment; Tumor immunotherapy  \nIntroduction  \nCancer progression is a complex, multistep process driven by coordinated interactions between immune and nonimmune cells, which collectively shape the tumor microenvironment (TME). This cellular interplay is governed by chemokines, small chemotactic cytokines that regulate cell migration through tightly controlled spatial and temporal expression. Chemokines are grouped into four subfamilies based on the arrangement of their N-terminal cysteine residues: Cysteine–Cysteine (C–C or CC), Cysteine–X–Cysteine (C–X–C or CXC), Cysteine– X3–Cysteine (C–X3–C or CXC), and X–Cysteine (X–Cor XC) motif ligands. They primarily signal through G protein-coupled receptors, which span the cell membrane seven times. In parallel, chemokines also bind atypical chemokine receptors (ACKRs), which share a similar structure but lack G protein signaling capacity. Instead of inducing traditional signaling pathways, ACKRs regulate  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000004009 |\n\nlocal chemokine levels by promoting their sequestration and degradation. To date, around 50 chemokines, 20 signaling G protein-coupled receptors, and 4 ACKRs have been identified. Although chemokines are involved in various nonimmune functions, they play essential roles in directing immune cell trafficking, activation, and communication. [1] Within the TME, chemokines contribute to both tumor-promoting and tumor-suppressive processes by modulating immune cell recruitment and behavior. Tumor and stromal cells secrete distinct chemokine profiles that  \nCorrespondence to: Yong Zhao, Institute of Cell and Gene Technology, Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen, Guangdong 518107","cbCaioQGyi04cpOv","https://ap.wps.com/l/cbCaioQGyi04cpOv","pdf",28541060,24,"English","# Abstract\n# Introduction\n## Chemokines in shaping the tumor microenvironment\n## Chemokine receptor signaling via GPCRs and ACKRs\n## Therapeutic relevance of chemokine-receptor interactions","[{\"question\":\"How do chemokines influence immune cell behavior in the tumor microenvironment?\",\"answer\":\"Chemokines control immune-cell trafficking, activation, and communication by regulating spatial and temporal expression, thereby shaping the immunological landscape in the TME.\"},{\"question\":\"What happens when chemokine gradients are disrupted?\",\"answer\":\"Disrupted chemokine gradients alter immune cell recruitment and activation and can also influence tumor cell proliferation, metastasis, and angiogenesis.\"},{\"question\":\"Why is the chemokine receptor axis considered a promising target for cancer immunotherapy?\",\"answer\":\"Dysregulated expression of chemokines and their receptors is strongly linked to tumor initiation, progression, and clinical outcomes, and receptor-mediated signaling offers actionable therapeutic routes.\"}]","Chemokine–chemokine receptor axis - Emerging immunotherapeutic paradigms for solid tumor microenvironment reprogramming | PDF",1790126601,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b504a7af151f696b1443e22a502bb748.webp",983,1324,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a2c02cbd1a3068cf39bb370c1d271eb.webp",982,1323,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1680a1fc62de92b1a7b1ec93d55f717d.webp",981,1321,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c9fa9da84546f31544d0e819ae2c818.webp",980,1320]